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Age and 'Strain-
transcending' Immunity to
Plasmodium falciparum
Roberts et 01. 1 cited work from this
laboratory-, which to them suggested that
'... immunity can develop after relatively
few (certainly less than 10) episodes of
clinical malaria'. Although this statement
appears largely true to the cited work, it is
important to point out that the supporting
evidence applied to adults but not to
children. In our studies of people with
limited histories of exposure to endemic
malaria, children remained susceptible to
frequent and high-grade parasitemia after
several years, whereas adults apparently
developed protection. These findings were
confirmed with additional studies]
A paradigm for the relationship between
antigenic variation and the development of
clinical immunity to falciparum malaria must
ultimately account for this important
difference between children and adults.
The thoughtful exchange between
Roberts et 01. 1 and Gupta and Day4 was
especially relevant in this regard. In the
original description of antigenic variation by
malaria parasites, Brown and Brown s
recorded in Plasmodium knowlesi what they
described as 'the simultaneous occurrence
Reply
Baird proposes that the rate of development
of clinical immunity to malaria may be very
different in children compared with adults.
He cites his own data from IrianJayaU
reporting age-related differences in
malariometric indices in Javanese
transmigrants and Melanesians to support
this hypothesis. The data presented by
Baird et 01. 1,2 show in some, but not all,
slide-positivity studies that Javanese adults
experience fewer parasitemic episodes of
Plasmodium falciparum than do children
from the same geographic origin. Data are
reported for the first two years of
residence of the Javanese migrants in a
holoendemic malaria area of Irian[aya,
The Javanese are believed to have no
previous history of exposure to malaria
before arriving in Irian[aya. This may be a
valid conclusion, but the reader of these
papers has to take this on faith, as malaria
prevalence figures given for the Javanese
islands are only from 1980. As there appear
to be subjects in the study population up
to 60 years of age, it would be interesting to
know the malaria-transmission conditions
that these older individuals were exposed
to in Java, Frequently, data are pooled for
all subjects> 15 years to define an adult age
class for comparison with children aged 2-5
years. This assumes that all subjects> 15
years have the same history of exposure to
of two levels of immunity, one specific for
each relapse variant, and the other
transcending antigenic variation ... '. They
cited work suggesting that' ... the young of
some hosts may be constitutionally
incapable of developing a generalized
[strain-transcending] immunity ... '.
Brown and Browns wondered whether
childhood susceptibility to infection was
due to a lack of experience with antigenic
variation (relative to adults) or to a
constitutional inabilityto respond
appropriately to endemic infection pressure.
That question burns today and bears
directly upon the arguments raised by
Roberts et 01. 1 and Gupta and Day",
In considering the issue of an immune
response which may transcend antigenic
variation, some important papers seemed
neglected. In addition to the work of Brown
and BrownS, Diggs et 0/6 reported dramatic
therapeutic effects of purified adult African
IgG against Asian isolates of P. falciparum in
Aotus monkeys. This was also true when
adult African IgG was injected into Thai
patients ill with P. falciparum? The clinical
studies of malariotherapy of syphilis patients
also offer evidence of strain-transcending
immunity. The work and review by Jeffery8
is instructive; patients with immunity to
homologous strains of P. falciparum usually
showed markedly attenuated susceptibility
to heterologous strains from widely
malaria. Is this the case? Small sample sizes
for individual villages also require data to
be pooled to observe the differences in
parasitemia rates between adults and
children". This is valid if there are no
significant inter-village differences in malaria
transmission. Given the above concerns,
the observed age-specific differences in
parasitic rates are justified if there are no
age-specific differences in either exposure
to transmission or antimalarial usage for the
Javanese population,
While these studies report interesting
findings, they do not directly address the
issue in question, ie. the age-specific rate of
development of clinical or anti-disease
immunity. They report age-specific
differences in the prevalence of parasitemia
but not clinical episodes of the Javanese
study population. Inthe design and discussion
of these studies, Baird et 01. do not draw any
distinction between anti-disease immunityand
anti-infection immunity which clearly develop
at quite different rates (see review by Gupta
and Day3) and persist for different periods"
Given this distinction, we believe that the
data of Bairdet 01. attempt to address the
question of the age dependence of the
development of infection -blocking rather
than anti-disease immunity. Consequently,
they are only relevant to the current
discussion if variant surface antigens are the
target of both types of immunity.
Epidemiological data from other areas
do not support Baird's hypothesis. For
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separated geographic regions. It may be
essential to recognize that all of the clinical
studies exploiting the practice of malaria
therapy used adult humans. Those findings
cannot be extrapolated to children. The
rate of development of clinical immunity to
homologous and heterologous strains of
parasites may be dramatically different in
children. The existence of a 'strain-
transcending' immune response may
be reconciled with data from adults but
not from children.
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example, clinical data from areas of low
endemnicity show little age dependence in .
the distribution of clinical cases. Similarly,
a study of epidemic malaria in Madagascar
has shown that all age classes except those
previously exposed to malaria were equally
susceptible to disease", We therefore do
not believe that there is sufficient, well-
defined clinical data to propose that an
age-dependent difference in the rate of
acquisition of immunity that protects
against malarial disease.
Baird also raises the issue of the
importance of strain-transcending immunity
in controlling disease. Our interpretation of
the induced experimental evidence is that
it is strain-specific rather than strain-
transcending immunity that protects against
disease. jeffery's review>, in fact, states
'... in all homologous species
reinoculations, there were significant
modifications of the infections, which
were enhanced if both exposures
were to the same strain. Variable
results were seen after re-inoculation
of patients with heterologous species.'
Similar points are made by Boydb and
Hackett", among others. We believe that,
in areas of high endemicity, strain-
transcending immunity plays an important
role in the eventual development of
immunity against infection, but not against
disease. For a more-detailed discussion of
these issues, see Gupta and Day3.
